Literature DB >> 33475808

[Overview: granulomatous diseases of the lung].

Florian Stellmacher1, Sven Perner2,3,4.   

Abstract

The spectrum of pulmonary granulomatoses is wide and includes infectious and noninfectious entities, each with very different therapeutic consequences. The first step of histological examination discriminates between necrotizing and non-necrotizing granulomatosis. After this, an infectious cause of the granulomatosis has to be excluded by special histological stains and molecular-pathologic methods, if necessary. Diagnosis also includes clinical, radiological, and microbiological findings. The process of pathological examination should be standardized as described.

Entities:  

Keywords:  Differential diagnoses granulomatoses; Epithelioid cell; Mycobacteriosis; Sarcoidosis; Vasculitis

Year:  2021        PMID: 33475808     DOI: 10.1007/s00292-020-00893-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  7 in total

1.  Characteristics of hypersensitivity pneumonitis diagnosed by interstitial and occupational lung disease multi-disciplinary team consensus.

Authors:  Gareth I Walters; Justin M Mokhlis; Vicky C Moore; Alastair S Robertson; Geraldine A Burge; Parminder S Bhomra; P Sherwood Burge
Journal:  Respir Med       Date:  2019-06-29       Impact factor: 3.415

Review 2.  Pathology of pulmonary tuberculosis and non-tuberculous mycobacterial lung disease: Facts, misconceptions, and practical tips for pathologists.

Authors:  Deepali Jain; Subha Ghosh; Lucileia Teixeira; Sanjay Mukhopadhyay
Journal:  Semin Diagn Pathol       Date:  2017-06-07       Impact factor: 3.464

Review 3.  [The multidisciplinary discussion-the gold standard in diagnosing interstitial lung diseases].

Authors:  Sabina Berezowska; Manuela Funke-Chambour; Alexander Pöllinger; Stephan C Schäfer
Journal:  Pathologe       Date:  2020-02       Impact factor: 1.011

4.  Histopathological spectrum of hypersensitivity pneumonitis with clinico-radiologic correlation.

Authors:  Suvradeep Mitra; Sahajal Dhooria; Ritesh Agarwal; Ashim Das; Mandeep Garg; Amanjit Bal
Journal:  APMIS       Date:  2019-09       Impact factor: 3.205

Review 5.  Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.

Authors:  Fabio Basta; Carmen Mazzuca; Eleonora Nucera; Domenico Schiavino; Antonella Afeltra; Raffaele Antonelli Incalzi
Journal:  Clin Exp Rheumatol       Date:  2020-02-18       Impact factor: 4.473

6.  Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis.

Authors:  Che-Liang Chung; Yen-Fu Chen; Yen-Ting Lin; Jann-Yuan Wang; Shuenn-Wen Kuo; Jin-Shing Chen
Journal:  BMC Infect Dis       Date:  2018-10-23       Impact factor: 3.090

7.  Idiopathic bronchocentric granulomatosis in an asthmatic adolescent.

Authors:  Hiroki Umezawa; Yusuke Naito; Takashi Ogasawara; Takao Takeuchi; Norio Kasamatsu; Ikko Hashizume
Journal:  Respir Med Case Rep       Date:  2015-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.